News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DBV Technologies Announces Creation Of US Subsidiary And Appoints Ms. Susanna Mesa As Vice President Of Finance, U.S. Investor Relations & Strategy


4/7/2014 9:13:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BAGNEUX, France, April 7, 2014 (GLOBE NEWSWIRE) -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345), creator of ViaskinĀ®, a new paradigm for the treatment of allergies, today announced that it has established a US subsidiary, DBV Technologies Inc., in order to conduct operations in the United States, and that it appointed Ms. Susanna Mesa as Vice President of Finance, US Investor Relations & Strategy.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES